mazindol has been researched along with Dystonia in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augood, SJ | 1 |
| Hollingsworth, Z | 1 |
| Albers, DS | 1 |
| Yang, L | 1 |
| Leung, J | 1 |
| Breakefield, XO | 1 |
| Standaert, DG | 1 |
1 other study available for mazindol and Dystonia
| Article | Year |
|---|---|
Dopamine transmission in DYT1 dystonia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Basal Ganglia; Benzamides; Benzazepines; Binding Si | 2004 |